SureScreen Diagnostic wins at the Medilink Midlands Business Awards 2022
SureScreen Diagnostics is celebrating its achievement of winning the Export Achievement award and being a finalist of the Delivering Innovation in Health and Care award at at the Medilink Midlands Business Awards 2022.
The annual Midilink Midlands Business Awards are a spectacular showcase of the very best collaborations between industry, academia, and the NHS across the Midlands. The awards see life science companies across the Midlands receive awards from Start-Up to Outstanding Achievements.
The awards are a fantastic opportunity for businesses to come together to celebrate the achievements of the life science companies in our magnificent region.
SureScreen were delighted to be the winner of the Export Achievement, which is awarded to companies which have experienced substantial growth in overseas earnings and commercial success. The company was also named as a finalist for Delivering Innovation in Health and Care, recognising companies for an innovation that is being adopted by the NHS and that has demonstrated an impact on efficacy, patient outcomes and NHS system costs.
The event was an exciting evening of celebration with over 140 industry professionals attending, with the opportunity to network with some inspiring companies and individuals.
Director, David Cambell said: “We are delighted to have been given the prestigious Medilink award for Export Achievement.”
“It is a great boost for our team who have dedicated themselves to producing the best possible tests for Covid-19.”
Founded in 1996, the family firm SureScreen Diagnostics has been at the heart of innovation – creating unique alcohol testing devices in ambulances, urine tests for GP surgeries and now the most accurate lateral flow tests for COVID-19. The rapid antigen tests for COVID-19 were the first European ones to pass the validation process in the laboratory by Public Health England and have been exported to 53 countries and dependencies. Thus far 30 million have also been produced for the UK government.
